Mouse Anti-ITPR1 Recombinant Antibody (2B6) (CBMAB-I0114-YY)
Datasheet
Target
References
Q & As
Review & reward
Protocols
Associated Products
Basic Information
Host Animal
Mouse
Clone
2B6
Application
ELISA
Specificity
Human
Antibody Isotype
IgG2a, κ
Clonality
Monoclonal
Application Notes
The COA includes recommended starting dilutions, optimal dilutions should be determined by the end user.
Formulations & Storage [For reference only, actual COA shall prevail!]
Format
Liquid
Buffer
PBS, pH 7.2
Storage
Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
More Infomation
Target
Full Name
Inositol 1,4,5-Trisphosphate Receptor Type 1
Introduction
This gene encodes an intracellular receptor for inositol 1,4,5-trisphosphate. Upon stimulation by inositol 1,4,5-trisphosphate, this receptor mediates calcium release from the endoplasmic reticulum. Mutations in this gene cause spinocerebellar ataxia type 15, a disease associated with an heterogeneous group of cerebellar disorders. Multiple transcript variants have been identified for this gene.
Entrez Gene ID
UniProt ID
Alternative Names
Inositol 1,4,5-Trisphosphate Receptor Type 1
Function
Intracellular channel that mediates calcium release from the endoplasmic reticulum following stimulation by inositol 1,4,5-trisphosphate (PubMed:27108797).
Involved in the regulation of epithelial secretion of electrolytes and fluid through the interaction with AHCYL1 (By similarity).
Plays a role in ER stress-induced apoptosis. Cytoplasmic calcium released from the ER triggers apoptosis by the activation of CaM kinase II, eventually leading to the activation of downstream apoptosis pathways (By similarity).
Involved in the regulation of epithelial secretion of electrolytes and fluid through the interaction with AHCYL1 (By similarity).
Plays a role in ER stress-induced apoptosis. Cytoplasmic calcium released from the ER triggers apoptosis by the activation of CaM kinase II, eventually leading to the activation of downstream apoptosis pathways (By similarity).
Biological Process
Calcium ion transport1 PublicationNAS:UniProtKB
Cell morphogenesisIEA:Ensembl
Endoplasmic reticulum calcium ion homeostasisIEA:Ensembl
Epithelial fluid transportIEA:Ensembl
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressISS:UniProtKB
Negative regulation of calcium-mediated signalingManual Assertion Based On ExperimentIDA:GO_Central
Post-embryonic developmentIEA:Ensembl
Regulation of autophagyManual Assertion Based On ExperimentTAS:ParkinsonsUK-UCL
Release of sequestered calcium ion into cytosolISS:UniProtKB
Response to hypoxiaManual Assertion Based On ExperimentIDA:BHF-UCL
Signal transduction1 PublicationNAS:UniProtKB
Voluntary musculoskeletal movementIEA:Ensembl
Cell morphogenesisIEA:Ensembl
Endoplasmic reticulum calcium ion homeostasisIEA:Ensembl
Epithelial fluid transportIEA:Ensembl
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stressISS:UniProtKB
Negative regulation of calcium-mediated signalingManual Assertion Based On ExperimentIDA:GO_Central
Post-embryonic developmentIEA:Ensembl
Regulation of autophagyManual Assertion Based On ExperimentTAS:ParkinsonsUK-UCL
Release of sequestered calcium ion into cytosolISS:UniProtKB
Response to hypoxiaManual Assertion Based On ExperimentIDA:BHF-UCL
Signal transduction1 PublicationNAS:UniProtKB
Voluntary musculoskeletal movementIEA:Ensembl
Cellular Location
Endoplasmic reticulum membrane; Cytoplasmic vesicle, secretory vesicle membrane; Cytoplasm, perinuclear region. Endoplasmic reticulum and secretory granules (By similarity).
Involvement in disease
Spinocerebellar ataxia 15 (SCA15):
Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.
Spinocerebellar ataxia 29 (SCA29):
An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor.
Gillespie syndrome (GLSP):
A rare disease characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive ataxia, progressive cerebellar atrophy, and mental retardation.
Spinocerebellar ataxia is a clinically and genetically heterogeneous group of cerebellar disorders. Patients show progressive incoordination of gait and often poor coordination of hands, speech and eye movements, due to degeneration of the cerebellum with variable involvement of the brainstem and spinal cord. SCA15 is an autosomal dominant cerebellar ataxia (ADCA). It is very slow progressing form with a wide range of onset, ranging from childhood to adult. Most patients remain ambulatory.
Spinocerebellar ataxia 29 (SCA29):
An autosomal dominant, congenital spinocerebellar ataxia characterized by early motor delay, hypotonia and mild cognitive delay. Affected individuals develop a very slowly progressive or non-progressive gait and limb ataxia associated with cerebellar atrophy on brain imaging. Additional variable features include nystagmus, dysarthria, and tremor.
Gillespie syndrome (GLSP):
A rare disease characterized by bilateral iris hypoplasia, congenital hypotonia, non-progressive ataxia, progressive cerebellar atrophy, and mental retardation.
Topology
Cytoplasmic: 1-2282
Helical: 2283-2303
Lumenal: 2304-2314
Helical: 2315-2335
Cytoplasmic: 2336-2361
Helical: 2362-2382
Lumenal: 2383-2405
Helical: 2406-2426
Cytoplasmic: 2427-2448
Helical: 2449-2469
Lumenal: 2470-2577
Helical: 2578-2598
Cytoplasmic: 2599-2758
Helical: 2283-2303
Lumenal: 2304-2314
Helical: 2315-2335
Cytoplasmic: 2336-2361
Helical: 2362-2382
Lumenal: 2383-2405
Helical: 2406-2426
Cytoplasmic: 2427-2448
Helical: 2449-2469
Lumenal: 2470-2577
Helical: 2578-2598
Cytoplasmic: 2599-2758
PTM
Phosphorylated on tyrosine residues.
Ubiquitination at multiple lysines targets ITPR1 for proteasomal degradation. Approximately 40% of the ITPR1-associated ubiquitin is monoubiquitin, and polyubiquitins are both 'Lys-48'- and 'Lys-63'-linked (By similarity).
Phosphorylated by cAMP kinase (PKA). Phosphorylation prevents the ligand-induced opening of the calcium channels. Phosphorylation by PKA increases the interaction with inositol 1,4,5-trisphosphate and decreases the interaction with AHCYL1.
Palmitoylated by ZDHHC6 in immune cells, leading to regulation of ITPR1 stability and function.
Ubiquitination at multiple lysines targets ITPR1 for proteasomal degradation. Approximately 40% of the ITPR1-associated ubiquitin is monoubiquitin, and polyubiquitins are both 'Lys-48'- and 'Lys-63'-linked (By similarity).
Phosphorylated by cAMP kinase (PKA). Phosphorylation prevents the ligand-induced opening of the calcium channels. Phosphorylation by PKA increases the interaction with inositol 1,4,5-trisphosphate and decreases the interaction with AHCYL1.
Palmitoylated by ZDHHC6 in immune cells, leading to regulation of ITPR1 stability and function.
Have you used Mouse Anti-ITPR1 Recombinant Antibody (2B6)?
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
$30 eGift Card
Submit a review
Submit a review and get a Coupon or an Amazon gift card. 20% off Coupon
Submit a review
Loading...
Please try the standard protocols which include: protocols, troubleshooting and guide.
For research use only. Not intended for any clinical use.
Custom Antibody Labeling
We also offer labeled antibodies developed using our catalog antibody products and nonfluorescent conjugates (HRP, AP, Biotin, etc.) or fluorescent conjugates (Alexa Fluor, FITC, TRITC, Rhodamine, Texas Red, R-PE, APC, Qdot Probes, Pacific Dyes, etc.).
Online InquiryContact us
Online Inquiry

